{"filing":{"accession_number":"0001193125-26-332748","cik":"0001527753","ticker":"PSNL","company_name":"Personalis, Inc.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"psnl-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1527753/000119312526332748/psnl-20260804.htm"},"events":[{"id":23887,"run_id":21604,"accession_number":"0001193125-26-332748","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Personalis issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $22.4 million (30% YoY growth), clinical revenue of $2.6 million (442% YoY growth), and clinical test volume of 10,384 tests (199% YoY growth). The filing includes consolidated statements of operations, balance sheets, and supplemental revenue information, all hallmarks of a quarterly earnings release under Item 2.02.","company_name":"Personalis, Inc.","ticker":"PSNL","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":24243,"accession_number":"0001193125-26-332748","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Personalis issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $22.4 million (30% YoY growth), clinical revenue of $2.6 million (442% YoY growth), and clinical test volume of 10,384 tests (199% YoY growth). The filing includes consolidated statements of operations, balance sheets, and supplemental revenue information, all hallmarks of a quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:25:23.941833+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24243,"accession_number":"0001193125-26-332748","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Personalis issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $22.4 million (30% YoY growth), clinical revenue of $2.6 million (442% YoY growth), and clinical test volume of 10,384 tests (199% YoY growth). The filing includes consolidated statements of operations, balance sheets, and supplemental revenue information, all hallmarks of a quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:25:23.941833+00:00","company_name":"Personalis, Inc.","ticker":"PSNL","filing_date":"2026-08-04"}]}